Humana Inc Etf Performance
| HUM Etf | USD 259.27 4.27 1.67% |
The etf retains a Market Volatility (i.e., Beta) of 1.84, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Humana will likely underperform.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Humana Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Etf's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the ETF investors. ...more
Forward Dividend Yield 0.0138 | Payout Ratio 0.2187 | Last Split Factor 3:2 | Forward Dividend Rate 3.54 | Dividend Date 2025-04-25 |
1 | Insider Trading | 12/31/2024 |
| Humana dividend paid on 31st of January 2025 | 01/31/2025 |
2 | Acentra Health Welcomes Distinguished Public Sector Health Leaders Calder Lynch and Jami Snyder to its Healthcare Advisory Board Appoints Julie Boughn as New Ch... | 02/04/2025 |
3 | CVS Health Surges on Strong Q4 Earnings and Strategic Focus for Future Growth | 02/12/2025 |
4 | Why Are Institutional Investors Increasing Their Holdings in Humana Inc. | 02/18/2025 |
5 | Plan Group Financial LLC Has 258,000 Stock Position in Humana Inc. | 02/19/2025 |
6 | Grow Therapy Launches AI-assisted Clinical Tools to Enhance Client and Provider Experience | 02/20/2025 |
7 | Dow dives 700 points as latest data raises alarms about slowing economy | 02/21/2025 |
| Begin Period Cash Flow | 4.7 B |
Humana |
Humana Relative Risk vs. Return Landscape
If you would invest 29,565 in Humana Inc on November 27, 2024 and sell it today you would lose (3,630) from holding Humana Inc or give up 12.28% of portfolio value over 90 days. Humana Inc is generating negative expected returns assuming volatility of 2.6097% on return distribution over 90 days investment horizon. In other words, 23% of etfs are less volatile than Humana, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Humana Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Humana's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Humana Inc, and traders can use it to determine the average amount a Humana's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.072
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HUM |
Estimated Market Risk
| 2.61 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Humana is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Humana by adding Humana to a well-diversified portfolio.
Humana Fundamentals Growth
Humana Etf prices reflect investors' perceptions of the future prospects and financial health of Humana, and Humana fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Humana Etf performance.
| Return On Equity | 0.0741 | ||||
| Return On Asset | 0.0407 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 40.37 B | ||||
| Shares Outstanding | 120.64 M | ||||
| Price To Earning | 19.12 X | ||||
| Price To Book | 1.89 X | ||||
| Price To Sales | 0.26 X | ||||
| Revenue | 117.76 B | ||||
| EBITDA | 3.12 B | ||||
| Cash And Equivalents | 5.06 B | ||||
| Cash Per Share | 143.73 X | ||||
| Total Debt | 11.72 B | ||||
| Debt To Equity | 0.85 % | ||||
| Book Value Per Share | 135.73 X | ||||
| Cash Flow From Operations | 2.97 B | ||||
| Earnings Per Share | 9.98 X | ||||
| Total Asset | 46.48 B | ||||
| Retained Earnings | 28.32 B | ||||
| Current Asset | 2.76 B | ||||
| Current Liabilities | 2.39 B | ||||
About Humana Performance
By examining Humana's fundamental ratios, stakeholders can obtain critical insights into Humana's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Humana is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. Humana operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 95500 people.| Humana Inc generated a negative expected return over the last 90 days | |
| Over 98.0% of the company shares are owned by institutional investors | |
| On 31st of January 2025 Humana paid $ 0.885 per share dividend to its current shareholders | |
| Latest headline from nypost.com: Dow dives 700 points as latest data raises alarms about slowing economy | |
| The fund retains all of the assets under management (AUM) in different types of exotic instruments |
Other Information on Investing in Humana Etf
Humana financial ratios help investors to determine whether Humana Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humana with respect to the benefits of owning Humana security.